{"id":"W3100629716","doi":"10.1200/jco.20.02672","title":"Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":614,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenvatinib; Sorafenib; Atezolizumab; Nivolumab; Regorafenib; Ramucirumab; Oncology; Bevacizumab; Internal medicine; Pembrolizumab; Hepatocellular carcinoma; Population; Cabozantinib; Cancer; Colorectal cancer; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004586244,0.0001525632,0.002562736,0.00007789723,0.00004961069,0.000005396513,0.0002521092,0.0004615292,0.0002019359],"category_scores_gemma":[0.009251284,0.0001016221,0.0007174849,0.000143567,0.0001945496,0.00007093855,0.00004297309,0.0009018632,0.00003349611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001242518,"about_ca_system_score_gemma":0.003656435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006062301,"about_ca_topic_score_gemma":0.000001043809,"domain_scores_codex":[0.9952445,0.000439421,0.003363637,0.0002371934,0.0003944793,0.0003207812],"domain_scores_gemma":[0.9933881,0.00290216,0.001479417,0.0001991204,0.00125841,0.0007728501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03021542,0.001403442,0.7814413,0.0001741502,0.0008834112,0.001375351,0.0002513591,0.00001371026,0.005370928,0.0002216189,0.05263094,0.1260184],"study_design_scores_gemma":[0.08178721,0.1162813,0.08163072,0.0002094873,0.001189323,0.001920068,0.0007544899,0.0164278,0.000754461,0.0006909815,0.698051,0.0003031246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9455568,0.003815435,0.007710577,0.03977435,0.0006660873,0.0008230102,0.000005509954,0.00001501384,0.001633209],"genre_scores_gemma":[0.959541,0.001946209,0.02388156,0.0113271,0.002952239,0.00001944798,0.000006476295,0.00002573517,0.0003002943],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6998106,"threshold_uncertainty_score":0.9990942,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2489958274625802,"score_gpt":0.5172099093082254,"score_spread":0.2682140818456452,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}